Q69: Neurology: PLAB/UK(MLA)/AKT Exam style question
Today we will discuss another Q69 Neurology PLAB 1/ UKMLA exam style question.
A 61-year-old woman presents to the emergency department with morning headaches, nausea, and vomiting. An urgent CT head reveals a mass within the right frontal lobe, and an MRI head confirms the presence of a glioblastoma surrounded by oedema. The neurosurgery team is consulted, and the patient is scheduled for surgical intervention. Which of the following management strategies is most appropriate to help prevent complications during surgery?
A. Preoperative administration of hypertonic saline
B. Preoperative initiation of dexamethasone therapy
C. Preoperative administration of mannitol
D. Immediate administration of chemotherapy
E. Preoperative administration of furosemide
The correct answer is B
Explanation
In patients with glioblastoma or other brain tumours, preoperative management with dexamethasone (option B) is often employed to reduce cerebral oedema and the associated mass effect, helping to minimize the risk of complications during surgery. Dexamethasone is a potent glucocorticoid steroid that effectively treats vasogenic oedema by reducing the breakdown of the blood-brain barrier.
Preoperative administration of hypertonic saline (option A) is not the standard approach for reducing cerebral oedema in brain tumour patients. Hypertonic saline may be used in the context of acute neurological emergencies to decrease intracranial pressure rapidly but is not the preferred choice in this scenario.
Mannitol (option C) is an osmotic diuretic commonly used to treat elevated intracranial pressure in acute settings, such as traumatic brain injury. However, in the context of preoperative management for brain tumours, dexamethasone is preferred due to its specific effects on vasogenic oedema.
Immediate administration of chemotherapy (option D) is not appropriate for preoperative management of glioblastoma. Chemotherapy is typically administered postoperatively, sometimes in conjunction with radiation therapy, as part of a multimodal treatment approach.
Furosemide (option E) is a loop diuretic that is not routinely used to treat cerebral oedema in brain tumour patients. While it can be helpful in managing fluid overload, it does not specifically target vasogenic oedema associated with brain tumours, making dexamethasone a more appropriate choice.
Other answer options are heavily discussed in our platform. Sign up for our PLAB or UKMLA services and get access to all the necessary materials required to pass the exam.
The above question is a high-yield exam PLAB 1 / UKMLA question-style question. At MedRevisions, We provide questions and not only explain the correct answer, we also explain the wrong answer so you will have a comprehensive understanding of the concepts that is commonly tested in the exam. On top of that, we also provide you PLAB 1 / UKMLA exam curated notes with no additional cost.
Join 100,000+ Members Study Group For UKMLA and PLAB 1 for FREE
At MedRevisions, we strive to provide the most up-to-date content available for the PLAB and UKMLA exams. We constantly add exam-style questions reflecting the high-yield concepts seen in recent exam trends and update our content to align with the latest NICE/CKS guidelines to help doctors prepare to pass the PLAB or UKMLA with confidence.
To discuss to more PLAB or UK-MLA exam style questions, Join: PLAB 1 /UKMLA exam study group
Past PLAB 1 candidates reviews about MedRevisions
Previous PLAB 1 or UKMLA exam guideline update
All MedRevisions recent updates
Check out this women's health PLAB 1 exam style question
Are you a UK Medical Student taking your finals? Read our specific guide on How to Pass the MSCAA Exam.
What we provide and why MedRevisions is the best question bank and Study material available for the PLAB or UKMLA exam:
5000+ Questions: Covering every inch of the MLA Content Map.
Integrated Notes: Tailored Study Notes: Our comprehensive notes cover all key PLAB 1/UKMLA topics with clear explanations and highlighted take-home points. They’re designed to complement the question bank and reinforce your knowledge, making your revision as efficient as possible. Every important guideline, investigation, and management point you need to know is distilled for quick understanding.
Smart Analytics: We visualize your progress, showing you exactly which AoCPs (Areas of Clinical Practice) are your strongest and weakest.
MedRevisions AI Professor for PLAB and UKMLA: Imagine having a medical professor sitting next to you 24/7. A professor who knows exactly what you are studying, understands your weak spots, never gets tired of your questions, and has instant access to over 5,000+ exam-style questions and verified study notes. Read more about how to use MedRevisions AI Professor
Realistic Exam Simulation: Our question bank closely mirrors recent PLAB/UKMLA exams in style and difficulty. You’ll go into the exam feeling as if you’ve seen it all before, familiar with the question formats and level of complexity in each topic area.
Always Updated: Content is continuously aligned with the latest MLA content map and UK medical guidelines – we update promptly after each exam and after any guideline change. This means you’re always revising with relevant, up-to-date material, and never studying outdated advice or superseded protocols.
Proven Success: We have a strong track record of helping candidates excel in the PLAB and UKMLA exams on their first attempt. Our users’ successes are a testament to the effectiveness of our approach – and your success is our success.
30+ Full Mock Exams: Hone your exam technique with our library of full-length mock exams. We offer over 30 realistic mocks that simulate the actual PLAB 1, so you can practice under exam conditions. Even better, you can reset and retake these mocks as many times as you want – each attempt will bring a new mix of questions, giving you virtually endless practice and helping build your stamina for the real exam.
Study Essential Mode: Use our specialised high-yield Study Essential Mode to focus on the ~1,800 most essential questions first (as discussed above), then tackle the remaining questions for complete coverage. This feature helps you prioritize efficiently, solidifying core topics before moving on to more advanced or niche areas – a perfect antidote to feeling overwhelmed.
Reference:
NICE guideline on brain tumours (primary) and brain metastases in over 16s, covers the diagnosis, monitoring and management of any type of primary brain tumour or brain metastases in adults. It includes recommendations on the use of corticosteroids, such as dexamethasone, to reduce cerebral oedema and improve symptoms.
The Alberta Health Services that provides recommendations on the use of dexamethasone in patients with high-grade gliomas and cerebral oedema. It covers the indications, dosage, duration, monitoring, and adverse effects of dexamethasone therapy. It states that treatment with the lowest possible dexamethasone dose is recommended for symptom relief in patients with primary high-grade gliomas and cerebral oedema, and that following surgery, a maximum dose of 16 mg daily, administered in twice-daily doses is recommended for symptomatic patients.
Neurosurgery Clinics of North America that reviews the perioperative management of patients with glioblastoma. It discusses the role of awake brain mapping, neoadjuvant modalities, and multidisciplinary teams in achieving optimal surgical outcomes. It also mentions that preoperative dexamethasone therapy is recommended to provide temporary symptomatic relief of symptoms related to increased intracranial pressure and oedema secondary to brain tumours.
